Metformin inhibited colitis and colitis-associated cancer (CAC) through protecting mitochondrial structures of colorectal epithelial cells in mice

References

• Abulí A, Lozano JJ, Rodríguez-Soler M, Jover R, Bessa X, Muñoz J, Esteban-Jurado C, Fernández-Rozadilla C, Carracedo A, Ruiz-Ponte C, et al. Genetic susceptibility variants associated with colorectal cancer prognosis. Carcinogenesis. 2013; 34(10): 2286–2291.doi:10.1093/carcin/bgt179.
   PubMed Web of Science ®Google Scholar
• Low D, Mino-Kenudson M, Mizoguchi E. Recent advancement in understanding colitis-associated tumorigenesis. Inflamm Bowel Dis. 2014;20(11):2115–2123. doi:10.1097/MIB.
   PubMed Web of Science ®Google Scholar
• Rogler G. Chronic ulcerative colitis and colorectal cancer. Cancer Lett. 2014;345(2):235–241. doi:10.1016/j.
   PubMed Web of Science ®Google Scholar
• Thent ZC, Zaidun NH, Azmi MF, Senin MI, Haslan H, Salehuddin R. Is metformin a therapeutic paradigm for colorectal cancer: insight into the molecular pathway?. Curr Drug Targets. 2017;18(6):734–750. doi:10.2174/1389450118666161205125548.
   PubMed Web of Science ®Google Scholar
• Koh SJ, Kim JM, Kim IK, Ko SH, Kim JS. Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer. J Gastroenterol Hepatol. 2014;29(3):502–510.
   PubMed Web of Science ®Google Scholar
• Cameron AR, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, McNeilly AD, Balfour DJ, Savinko T, Wong AK, et al. Anti-inflammatory effects of metformin irrespective of diabetes status. Circ Res. 2016; 119(5): 652–665.doi:10.1161/CIRCRESAHA.116.308445.
   PubMed Web of Science ®Google Scholar
• Goodwin PJ. Obesity and breast cancer outcomes: how much evidence is needed to change practice?. J Clin Oncol. 2016;34(7):646–648. doi:10.1200/JCO.
   PubMed Web of Science ®Google Scholar
• Fowke JH, Motley SS. Statin use linked with a decrease in the conversion from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer. Carcinogenesis. 2018;39(6):819–825. doi:10.1093/carcin/bgy050.
   PubMed Web of Science ®Google Scholar
• Zi F, Zi H, Li Y, He J, Shi Q, Cai Z. Metformin and cancer: an existing drug for cancer prevention and therapy. Oncol Lett. 2018;15(1):683–690. doi:10.3892/ol.2017.7412.
   PubMed Web of Science ®Google Scholar
• Seo YS, Kim YJ, Kim MS, Suh KS, Kim SB, Han CJ, Kim YJ, Jang WI, Kang SH, Tchoe HJ, et al. Association of metformin use with cancer-specific mortality in hepatocellular carcinoma after curative resection: a nationwide population-based study. Medicine (Baltimore). 2016; 95(17): e3527.doi:10.1097/MD.0000000000003527.
   PubMed Web of Science ®Google Scholar
• Kim J, You YJ. Regulation of organelle function by metformin. IUBMB Life. 2017;69(7):459–469. doi:10.1002/iub.1633.
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B, Cheng G, Hardy M, Ouari O, Sikora A, Zielonka J, Dwinell MB. Modified metformin as a more potent anticancer drug: mitochondrial inhibition, redox signaling, antiproliferative effects and future EPR studies. Cell Biochem Biophys. 2017;75(3–4):311–317. doi:10.1007/s12013-017-0796-3.
   PubMed Web of Science ®Google Scholar
• Hardie DG. Keeping the home fires burning: AMP-activated protein kinase. J R Soc Interface. 2018;15:.138. doi:10.1098/rsif.2017.0774.
   Web of Science ®Google Scholar
• Chen X, Li X, Zhang W, He J, Xu B, Lei B, Wang Z, Cates C, Rousselle T, Li J. Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway. Metabolism. 2018;83:.256–270. doi:10.1016/j.metabol.2018.03.004.
   PubMed Web of Science ®Google Scholar
• Pan Y, Liu L, Li S, Wang K, Ke R, Shi W, Wang J, Yan X, Zhang Q, Wang Q, et al. Activation of AMPK inhibits TGF-β1-induced airway smooth muscle cells proliferation and its potential mechanisms. Sci Rep. 2018; 8(1): 3624.doi:10.1038/s41598-018-21812-0.
   PubMedGoogle Scholar
• Chung EJ, Do EJ, Kim SY, Cho EA, Kim DH, Pak S, Hwang SW, Lee HJ, Byeon JS, Ye BD, et al. Combination of metformin and VSL#3 additively suppresses western-style diet induced colon cancer in mice. Eur J Pharmacol. 2017;794:1–7. doi:10.1016/j.ejphar.2016.11.012.
   PubMed Web of Science ®Google Scholar
• Vendramini-Costa DB, Francescone R, Posocco D, Hou V, Dmitrieva O, Hensley H, de Carvalho JE, Pilli RA, Grivennikov SI. Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis. Carcinogenesis. 2017;38(1):51–63. doi:10.1093/carcin/bgw112.
   PubMed Web of Science ®Google Scholar
• Justino PF, Melo LF, Nogueira AF, Costa JV, Silva LM, Santos CM, Mendes WO, Costa MR, Franco AX, Lima AA, et al. Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice. Br J Nutr. 2014; 111(9): 1611–1621.doi:10.1017/S0007114513004248.
   PubMed Web of Science ®Google Scholar
• Grivicich I, Regner A, Da Rocha AB, Grass LB, Alves PA, Kayser GB, Schwartsmann G, Henriques JA. Irinotecan/5-fluorouracil combination induces alterations in mitochondrial membrane potential and caspases on colon cancer cell lines. Oncol Res. 2005;15(7–8):385–392.
   PubMed Web of Science ®Google Scholar
• Wu KY, Lai YH, Yang YC, Wu WC, Hong SJ. 5-Fluorouracil-induced apoptosis changes in cultured corneal epithelial cells. J Ocul Pharmacol Ther. 2016;32(3):155–162. doi:10.1089/jop.2015.0109.
   PubMed Web of Science ®Google Scholar
• Bessler H, Straussberg R, Alexandrova S, Beilin B, Djaldetti M, Hart J. Effect of oral chemotherapy on the mitochondrial size of mouse intestinal cells. Cancer Chemother Pharmacol. 1996;38(1):35–38. doi:10.1007/s002800050444.
   PubMed Web of Science ®Google Scholar
• Wang H, Bastian SE, Cheah KY, Lawrence A, Howarth GS. Escherichia coli Nissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage. Cancer Biol Ther. 2014;15(5):560–569. doi:10.4161/cbt.28159.
   PubMed Web of Science ®Google Scholar
• Cheah KY, Howarth GS, Yazbeck R, Wright TH, Whitford EJ, Payne C, Butler RN, Bastian SE. Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis. Cancer Biol Ther. 8;2009:382–390.
   PubMed Web of Science ®Google Scholar
• Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138:.2101–2114. doi:10.1053/j.gastro.2010.01.058.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li S, Cao Y, Tian X, Zeng R, Liao DF, Cao D. Oxidative stress and carbonyl lesions in ulcerative colitis and associated colorectal cancer. Oxid Med Cell Longev. 2016;2016:.9875298. doi:10.1155/2016/9875298.
   PubMed Web of Science ®Google Scholar
• Wang X, Mandal AK, Saito H, Pulliam JF, Lee EY, Ke ZJ, Lu J, Ding S, Li L, Shelton BJ, et al. Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitis-associated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/β-catenin signaling pathway. Toxicol Appl Pharmacol. 2012; 262(1): 11–21.doi:10.1016/j.taap.2012.04.014.
   PubMed Web of Science ®Google Scholar
• Waldner MJ, Neurath MF. Mechanisms of immune signaling in colitis-associated cancer. Cell Mol Gastroenterol Hepatol. 2014;1(1):6–16. doi:10.1016/j.jcmgh.2014.11.006.
   PubMed Web of Science ®Google Scholar
• Hibiya S, Tsuchiya K, Hayashi R, Fukushima K, Horita N, Watanabe S, Shirasaki T, Nishimura R, Kimura N, Nishimura T, et al. Long-term inflammation transforms intestinal epithelial cells of colonic organoids. J Crohns Colitis. 2017; 11(5): 621–630.doi:10.1093/ecco-jcc/jjw186.
   PubMed Web of Science ®Google Scholar
• Zhao B, Kang Q, Peng Y, Xie Y, Chen C, Li B, Wu Q. Effect of angelica sinensis root extract on cancer prevention in different stages of an AOM/DSS mouse model. Int J Mol Sci. 2017;18:.8. doi:10.3390/ijms18081750.
   Web of Science ®Google Scholar
• Pickrell AM, Fukui H, Wang X, Pinto M, Moraes CT. The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions. J Neurosci. 2011;31(27):9895–9904. doi:10.1523/JNEUROSCI.6223-10.2011.
   PubMed Web of Science ®Google Scholar
• Dalva-Aydemir S, Bajpai R, Martinez M, Adekola KU, Kandela I, Wei C, Singhal S, Koblinski JE, Raje NS, Rosen ST, et al. Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin. Clin Cancer Res. 2015; 21(5): 1161–1171.doi:10.1158/1078-0432.CCR-14-1088.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhu XD, Wang WQ, Shen Y, Qin Y, Ren ZG, Sun HC, Tang ZY. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res. 2010;16(10):2740–2750. doi:10.1158/1078-0432.CCR-09-2610.
   PubMed Web of Science ®Google Scholar
• Shackelford DB, Vasquez DS, Corbeil J, Wu S, Leblanc M, Wu CL, Vera DR, Shaw RJ. mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc Natl Acad Sci USA. 2009;106(27):11137–11142. doi:10.1073/pnas.0900465106.
   PubMed Web of Science ®Google Scholar
• Loubiere C, Clavel S, Gilleron J, Harisseh R, Fauconnier J, Ben-Sahra I, Kaminski L, Laurent K, Herkenne S, Lacas-Gervais S, et al. The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells. Sci Rep. 2017; 7(1): 5040.doi:10.1038/s41598-017-05052-2.
   PubMedGoogle Scholar
• Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001; 108(8): 1167–1174.doi:10.1172/JCI13505.
   PubMed Web of Science ®Google Scholar
• Shackelford BD, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumor suppression. Nat Rev Cancer. 2009;9(8):563–575. doi:10.1038/nrc2676.
   PubMed Web of Science ®Google Scholar
• Sun X, Yang Q, Rogers CJ, Du M, Zhu MJ. AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression. Cell Death Differ. 2017;24(5):819–831. doi:10.1038/cdd.2017.14.
   PubMed Web of Science ®Google Scholar
• Martin H, Joëlle D, Bertrand D, Patricia L, Alain G, Patrick CE, Pascale C, Yves LB. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 2003;421(6919):182–187. doi:10.1038/nature01298.
   PubMed Web of Science ®Google Scholar
• Meidenbauer JJ, Ta N, Seyfried TN. Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice. Nutr Metab (Lond). 2014;11:.23. doi:10.1186/1743-7075-11-23.
   PubMed Web of Science ®Google Scholar
• Parang B, Barrett CW, Williams CS. AOM/DSS model of colitis-associated cancer. Methods Mol Biol. 2016;1422:.297–307. doi:10.1007/978-1-4939-3603-8_26.
   PubMedGoogle Scholar
• Thangthaeng N, Rutledge M, Wong JM, Vann PH, Forster MJ, Sumien N. Metformin imparis spatial memory and visual acuity in old male mice. Aging Dis. 2017;8(1): 17–30. doi:10.14336/AD.2016.1010.
   Google Scholar
• Ke M, Wang H, Zhou Y, Li J, Liu Y, Zhang M, Dou J, Xi T, Shen B, Zhou C. SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice. Oncotarget. 2016;7(31):49509–49526. doi:10.18632/oncotarget.10375.
   PubMedGoogle Scholar
• Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69(2):238–249.
   PubMed Web of Science ®Google Scholar
• Anzai H, Hata K, Kishikawa J, Ishii H, Yasuda K, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, et al. Appendiceal orifice inflammation is associated with proximal extension of disease in patients with ulcerative colitis. Colorectal Dis. 2016; 18(8): O278–82.doi:10.1111/codi.13435.
   PubMed Web of Science ®Google Scholar
• Moniruzzaman M, Ghosal I, Das D, Chakraborty SB. Melatonin ameliorates H2O2-induced oxidative stress through modulation of Erk/Akt/NFkB pathway. Biol Res. 2018;51(1):17. doi:10.1186/s40659-018-0168-5.
   PubMed Web of Science ®Google Scholar
• Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Metformin is an AMP kinase–dependent growth inhibitor for breast cancer cells. Cancer Res. 2006;66(21):10269–10273. doi:10.1158/0008-5472.CAN-06-1500.
   PubMed Web of Science ®Google Scholar